A new ground-breaking technology was recently used at the University of Ottawa Heart Institute (UOHI) where two cardiologists, Dr. David Birnie and Dr. Pablo Nery, implanted a new innovative leadless defibrillator, the subcutaneous implantable cardioverter defibrillator (S-ICD), to a 18 year-old patient. Under Health Canada‘s special access program, this was only the third time this new type of ICD had been implanted in Canada.
Conventional defibrillators, known as transvenous defibrillators, are implanted with wires, called the leads, that snake through veins into the heart. When the defibrillator identifies any dangerous heartbeat, it delivers a shock through the wires to return the heart to its normal rhythm and allow it to get back to pumping blood steadily throughout the body.
Scientists from India and Canada are collaborating on the development of a new imaging technology focussed on brain tumours. The bilateral project—Improving the Detection, Diagnosis and Treatment of Brain Tumours—is valued at almost US$1.7 million and aims to develop and commercialise software that will provide radiologists with enhanced automated imaging methods to detect and characterise brain tumours and enable accelerated assessment and treatment.
Leveraging $486,000 from ISTP Canada and additional funding from the Department of Biotechnology (DBT) in India, the team is tasked with creating a new imaging technology that automatically locates, maps and monitors tumour changes and combines MRI and PET image data into a single information-rich diagnostic tool.
The conference should give a forum for information exchange among theoreticians, engineers, and medical people. Original papers, research results, and contributions concerning interesting technical solutions will be appreciated as well as clinical experiences and survey lectures for presentation in the following areas:
Considering the fact the inclination of majority of students towards more stream-lined courses, Diploma In Medical Radio-Isotope Techniques might seem to be in first place a very obvious second alternative. However, they must also understand that this second alternative is designed in such a way that has a special focus to equip candidates for working in Nuclear Medicine Centers, which in itself would be an achievement.
Eligibility Criteria
Students aspiring to pursue this course should have B.Sc. Degree with at least 60% marks in Science or applied subjects of Science like Chemistry, Life Sciences, Physics, Biochemistry, Microbiology, Biotechnology, Biophysics, Nuclear Medicine Technology, Medical Radiological Technology. Candidates with M.Sc. Degree can also apply.
Under the India–Canada Agreement for Scientific and Technological Cooperation, the Governments of India and Canada have agreed to foster joint research and development (R&D) projects. This India-Ontario (Canada) Call for Proposals (CFP) will be delivered by the Global Innovation & Technology Alliance (GITA), a non-governmental organization, engaged by the Department of Science and Technology (DST), Government of India on the Indian side; and by International Science and Technology Partnership Canada (ISTPCanada), a non-governmental organization selected by the Ministry of Research and Innovation (MRI), Government of Ontario on the Canadian side. In Ontario (Canada), ISTP Canada is responsible for the implementation of the Ontario/India Collaborative Research Fund, which directly supports four goals established bythe Government of Ontario.
The Unit of Work Environment Toxicology seeks Post Doc / PhD candidates for development and application of advanced mathematical models related to toxicological risk assessment. The research will be carried out within three projects, namely:
– Development of PBPK models for nano particles
– Toxicokinetic population models as basis for biomonitoring
– Improvements in dose-effect analysis to refine and reduce animal experiments
A substantial part of the work relates to PBPK and Benchmark-Dose (BMD) model development and computer simulations of the toxicokinetic behavior of nanoparticles and biomarkers, as well as dose-biomarker and dose-response relationships. Collaboration with various other research groups is foreseen.
Time period: 2 years (post doc) or 4 years (Ph D student)
